Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant

This case series study assesses whether a fourth dose of a SARS-CoV-2 messenger RNA (mRNA)–based vaccine is associated with improved anti–SARS-CoV-2 antibody response in solid organ transplant recipients in France.

Detalles Bibliográficos
Autores principales: Kamar, Nassim, Abravanel, Florence, Marion, Olivier, Romieu-Mourez, Raphaelle, Couat, Chloé, Del Bello, Arnaud, Izopet, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613594/
https://www.ncbi.nlm.nih.gov/pubmed/34817587
http://dx.doi.org/10.1001/jamanetworkopen.2021.36030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613594/
https://www.ncbi.nlm.nih.gov/pubmed/34817587
http://dx.doi.org/10.1001/jamanetworkopen.2021.36030

Ejemplares similares